(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
@ $46.21
Issued: 14 Feb 2024 @ 12:06
Return: -22.48%
Previous signal: Feb 14 - 09:30
Previous signal:
Return: -4.71 %
Live Chart Being Loaded With Signals
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs...
Stats | |
---|---|
Today's Volume | 600 783 |
Average Volume | 585 369 |
Market Cap | 1.67B |
EPS | $0 ( 2024-05-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -14.74 |
ATR14 | $0.0920 (0.26%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-17 | Fmr Llc | Buy | 0 | |
2024-03-15 | Lin Xichen | Buy | 213 486 | Stock Option (right to buy) |
2024-03-15 | Bach Mark Allen | Buy | 65 352 | Stock Option (right to buy) |
2024-03-15 | Ma Yingli | Buy | 91 494 | Stock Option (right to buy) |
2024-03-15 | Yoon Jun | Buy | 148 134 | Stock Option (right to buy) |
INSIDER POWER |
---|
30.66 |
Last 43 transactions |
Buy: 9 065 015 | Sell: 6 065 489 |
Volume Correlation
Structure Therapeutics Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Structure Therapeutics Correlation - Currency/Commodity
Structure Therapeutics Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-949 174 (0.00 %) |
EPS: | $-2.44 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-949 174 (0.00 %) |
EPS: | $-2.44 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-623 258 (0.00 %) |
EPS: | $-1.400 |
Financial Reports:
No articles found.
Structure Therapeutics
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension; and LTSE-2578, an investigational oral small molecule lysophosphatidic acid 1 receptor antagonist for the treatment of IPF. The company was formerly known as ShouTi Inc. Structure Therapeutics Inc. was founded in 2016 and is headquartered in South San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators